1 |
cannabinoid receptor 1
(549 times)
|
Neurology (133 times)
|
CB2R (39 times) ECS (39 times) 2-AG (34 times)
|
2001 Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.
|
2 |
CB1 receptor
(142 times)
|
Neurology (46 times)
|
BLA (11 times) CB2R (11 times) eCB (10 times)
|
2004 Voluntary exercise augments acute effects of CB1-receptor inverse agonist on body weight loss in obese and lean mice.
|
3 |
CB1 cannabinoid receptor
(32 times)
|
Molecular Biology (7 times)
|
2-AG (4 times) 7-NI (2 times) AEA (2 times)
|
2000 Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system.
|
4 |
cannabinoid 1 G protein-coupled receptor
(2 times)
|
Drug Design (1 time)
|
---
|
2012 Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.
|
5 |
cannabinoid receptor type 1 receptor
(2 times)
|
Brain (1 time)
|
EA (2 times) ACEA (1 time) MnSOD (1 time)
|
2010 Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats.
|
6 |
CB1 receptor expression
(2 times)
|
Psychopharmacology (1 time)
|
FCA (1 time) GABA (1 time) OEA (1 time)
|
2020 Attentional set shifting in HAP3, LAP3, and cHAP mice is unaffected by either genetic differences in alcohol preference or an alcohol drinking history.
|
7 |
cannabinoid receptor 1 agonist
(1 time)
|
Neurology (1 time)
|
Cdk5 (1 time) FEP (1 time) NMDAR (1 time)
|
2022 Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids.
|
8 |
Cannabinoids bind central type 1 receptors
(1 time)
|
Physiology (1 time)
|
DMV (1 time) NTS (1 time)
|
2004 Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve.
|
9 |
CB subtype-1 receptor
(1 time)
|
Molecular Biology (1 time)
|
CB (1 time) CCK-INTs (1 time) THC (1 time)
|
2016 Persistent inhibitory circuit defects and disrupted social behaviour following in utero exogenous cannabinoid exposure.
|
10 |
CB1 subtype of cannabinoid receptors
(1 time)
|
|
2-AG (1 time) AEA (1 time) CESD-R (1 time)
|
2021 Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors.
|
11 |
CB1R-KO mice
(1 time)
|
Neurology (1 time)
|
DA (1 time) EAE (1 time) IL-1beta (1 time)
|
2016 Interaction between interleukin-1beta and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis.
|
12 |
CB1R-nulls
(1 time)
|
Neurology (1 time)
|
BW (1 time) GHS-R (1 time) GHSR (1 time)
|
2019 Combined Loss of Ghrelin Receptor and Cannabinoid CB1 Receptor in Mice Decreases Survival but does not Additively Reduce Body Weight or Eating.
|
13 |
CB1R-WT
(1 time)
|
Endocrinology (1 time)
|
beta-arr2 (1 time)
|
2014 Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.
|
14 |
CB2R affinity (K(i) = 1.0 nM), accompanied by interesting K(i)
(1 time)
|
Chemistry (1 time)
|
---
|
2014 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.
|
15 |
central type-1 cannabinoid receptor
(1 time)
|
Endocrinology (1 time)
|
ECS (1 time)
|
2022 Cross-talk between neurosteroid and endocannabinoid systems in cannabis addiction.
|
16 |
compare binding of the type 1 cannabinoid receptor
(1 time)
|
Neurology (1 time)
|
---
|
2011 Interictal type 1 cannabinoid receptor binding is increased in female migraine patients.
|
17 |
CRIP1b, multiple hydrogen bond interactions between Asn437
(1 time)
|
Chemistry (1 time)
|
---
|
2019 Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).
|
18 |
peripheral-cannabinoid receptor 1
(1 time)
|
Chemistry (1 time)
|
OCR (1 time) RIM (1 time) T2D (1 time)
|
2020 A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.
|